Regulus Therapeutics
RGLS
#6895
Rank
โ‚ฌ0.49 B
Marketcap
7,12ย โ‚ฌ
Share price
0.00%
Change (1 day)
412.58%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚ฌ0.49 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of โ‚ฌ0.49 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.48 B396.14%
2024โ‚ฌ96.93 M313.97%
2023โ‚ฌ23.41 M8.87%
2022โ‚ฌ21.5 M-47.03%
2021โ‚ฌ40.6 M-41.75%
2020โ‚ฌ69.7 M317.4%
2019โ‚ฌ16.69 M132.8%
2018โ‚ฌ7.17 M-92.04%
2017โ‚ฌ90.1 M-20.41%
2016โ‚ฌ0.11 B-73.05%
2015โ‚ฌ0.42 B-34.93%
2014โ‚ฌ0.64 B188.67%
2013โ‚ฌ0.22 B31.03%
2012โ‚ฌ0.17 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚ฌ92.13 B 18,585.38%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ23.35 B 4,635.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ105.52 B 21,301.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ254.94 B 51,604.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ91.10 B 18,376.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚ฌ0.11 B-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ2.59 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ36.43 B 7,289.99%๐Ÿ‡บ๐Ÿ‡ธ USA